The short answer
Associate veterinarians reach ownership by three main routes, according to the advisers cited here: starting a new practice, buying into an existing one over time, or buying a practice outright. A buy-in means purchasing a minority or majority stake in a hospital that already has at least one other owner. It can be funded by bank loans, installment arrangements, or in some cases sweat equity. The terms depend on how the practice is organized for tax purposes, how it is valued, and what the shareholder agreements say. Corporate consolidators have made the profitable multi-doctor practices harder for individual buyers to win. Broker and consultant sources therefore describe smaller practices and minority stakes alongside corporate owners as live alternatives.
Key takeaways
- Consultant Stith Keiser defines a buy-in as "acquiring a minority or majority stake in an existing hospital" where the buyer has at least one other partner [3].
- Attorneys Peter Tanella and Jason Marx write that an S corporation may have only one class of stock, which shapes how associate equity can be designed [2].
- Keiser cites the 2018 Well-Managed Practice Benchmarks Study as showing that practice owners "earned almost 25% more than associate veterinarians" [3].
- Simmons & Associates authors advise buyers to test the asking price with a feasibility analysis. They put the typical span from letter of intent to closing at 2 to 4 months [5].
- The SBA lists changes of ownership, "complete or partial," among allowed uses of 7(a) loans, which have a maximum of $5 million [6].
- Broker David King writes that consolidators often bid well above fair market value for desirable practices, which can take an associate's buy-in off the table [4].
The three routes to ownership
Keiser groups the options as the startup, the buy-in, and the buyout [3], and King of Simmons & Associates uses the same three categories [4].
Keiser writes that a startup gives the founder control over location, layout, and how medicine is practiced. It also requires a business plan that lenders will usually ask for [3]. He lists the drawbacks as harder financing without a track record, construction and lease delays, no income at the start, and an owner who covers many roles at once [3].
King says startups are becoming less common for two reasons [4]:
- Heavy student loan payments make months without income hard to absorb.
- A new clinic competes with consolidators for clients and staff.
Leslie Mamalis, a certified valuation analyst, notes that a startup owner's first paycheck "likely will be months away" [1].
A buyout, which Keiser also calls a turnkey deal, is the purchase of an entire practice, alone or with a partner [3]. He describes three advantages: immediate income from booked appointments, more autonomy for a sole owner, and easier bank financing when a practice is fairly priced. These are offset by higher cost than a buy-in and the risk of losing staff and clients during the transition [3].
What a buy-in involves
Keiser lists four attractions of a buy-in [3]:
- Lower risk, when the buyer understands the financials and shares the partners' philosophy.
- An investment that should pay for itself through return-on-investment checks, if the practice is valued correctly.
- Flexible financing.
- Mentorship from a more experienced owner.
On financing, he writes that he has seen friends buy in without a down payment or loan, through sweat equity or by giving up the production part of their pay [3].
The drawbacks he names are as follows [3]:
- A slow process involving lenders and attorneys.
- Limited say until the buyer holds a majority, unless the operating agreement provides otherwise.
- What he calls "golden handcuffs," where a senior owner who promised a full sale decides to keep the associate as a permanent minority partner.
He also flags noncompete agreements for anyone who later sells a share and leaves [3].
Equity structures
Tanella and Marx describe several ways an owner can offer equity or equity-like rewards [2]:
| Structure | How it works, per Tanella and Marx [2] |
|---|
| Direct stock purchase | The associate buys shares, typically at fair market value, and receives income and distributions in proportion to ownership. Sellers generally recognize a capital gain. |
| Restricted stock grant | Shares are granted as compensation and vest over time or on milestones. Ordinary income tax may apply at vesting unless a Section 83(b) election is made. |
| Profit sharing or bonus | Extra pay tied to profit or production, treated as wages, with no ownership or governance rights. |
| Phantom equity | A contract right to cash payments that mirror equity value, with no shares issued. Payouts are generally taxed as ordinary income. |
The authors note that a direct purchase requires a defensible, periodically updated valuation. It also requires updated shareholder agreements covering transfer restrictions, buy-sell terms, valuation methods, and dispute resolution [2].
They describe a phased approach as the most effective strategy in many practices: non-equity incentives first, with a stated path to ownership later [2].
They also warn that in multi-site S corporations, tying a shareholder's total pay and distributions to one location's profits can violate the single-class-of-stock rule [2]. Ownership rules for professional entities vary by state, they add [2].
The financial case as advisers present it
Keiser cites the 2018 Well-Managed Practice Benchmarks Study for two figures [3]:
- Owners "earned almost 25% more than associate veterinarians."
- An associate with six to 10 years of experience "earning a median income of $93,000 took home $213,611 less a year than a practice owner."
His article does not describe the study's design or sample, and the data are from 2018.
He breaks owner pay into separate streams [3]:
- Production pay as a veterinarian.
- A management share. He suggests 3% to 5% of gross revenue, split among those in management.
- A return on invested capital.
- Rent, if the owner holds the real estate in a separate entity.
- Equity at sale.
He says he targets a 10% annual return on his investment, reasoning that the stock market returns about the same on average [3].
Simmons & Associates authors Sherry Everhart and David King offer a hypothetical built on their own assumptions, not survey data [5]. In it:
- An associate earning $125,000 invests $20,000 a year at an 8% return.
- An owner buys a practice grossing $1,000,000 for $800,000 on a 10-year loan at 6.5%.
- The owner draws a comparable $125,000 production salary plus 1% to 2% of gross for leadership.
- Practice value grows 2% a year.
After 10 years, they calculate the associate's net worth at $262,295 and the owner's at $1,237,490, including $975,195 in equity [5]. They also note the financial risk of meeting debt payments and the added management time [5].
Financing and the purchase process
The SBA describes its 7(a) program as its primary business loan program [6]. It works as a guarantee to lenders rather than direct lending, and its uses include changes of ownership, complete or partial [6]. Eligibility requires that the business [6]:
- Be small under SBA standards.
- Be creditworthy, with a reasonable ability to repay.
- Be unable to get the credit on reasonable terms elsewhere.
The SBA page does not address veterinary practices specifically, and none of the cited sources gives current loan rates.
Everhart and King write that many successful buyers carried large student debt and little savings but had a high credit score [5]. Their outline of the process runs as follows [5]:
- Confirm financing with a veterinary lender.
- Have an attorney prepare a letter of intent.
- Draft an asset purchase agreement, including the seller's noncompete.
- Complete due diligence on productivity, fees, financial statements, equipment, and staff.
They describe the seller's appraisal as setting the price and the buyer's feasibility analysis as testing it, answering "Is there adequate cash flow to fund this deal?" [5]. They caution buyers against quitting a job or selling a house before closing [5].
When a consolidator outbids the associate
King writes that consolidators target profitable multi-doctor practices and often offer above fair market value [4]. He urges associates on a buy-in track to make sure it does not become "a dead-end after several years of waiting" [4]. Keiser reports three associates calling him after owners who had committed to selling to them sold to consolidators instead [3].
Mamalis lists the remaining options as working for the corporate owner, buying a minority interest alongside the consolidator, buying a different practice, or starting one [1].
On minority stakes, she notes that consolidator financing may be less competitive than a commercial loan and that the resale price is often capped [1]. Her example is that a stake bought at seven times earnings sells at the same multiple [1].
She and King both point to single-doctor and smaller practices as targets for individual buyers [1][4]. Mamalis says single-doctor practices are not "corporate magnets" [1]. King cites one- to two-doctor practices grossing under $1.5M with average profitability as a viable path [4].
